Patients with multiple tumors in the same breast who underwent a lumpectomy followed by radiation therapy had local recurrence rates comparable to those historically observed in patients with a single tumor, according to ...
Dec 9, 2022
0
2
Residual tumors from Black patients with estrogen receptor (ER)-positive/HER2-negative primary breast cancer treated with neoadjuvant chemotherapy (NAC) had a higher score of a biomarker of distant metastatic recurrence than ...
Dec 6, 2022
0
2
In a study using a first-of-its kind mouse model of aging that mimics breast cancer development in estrogen receptor-positive post-menopausal women, investigators at Georgetown Lombardi Comprehensive Cancer Center and colleagues ...
Dec 1, 2022
0
2
Less than 20% of diagnosed breast cancers are designated "triple-negative," lacking three types of receptors often found in other breast cancer types. But TNBCs have a higher risk of recurrence, metastasis and mortality. ...
Nov 30, 2022
0
8
One of the most puzzling—and devastating—aspects of cancer is its potentially lethal wanderlust, the spread of the disease from a primary tumor to a new and distant site.
Researchers have identified a protein that, when present in high amounts in breast cancer tumors, is an indicator of whether DNA-damaging therapies will work or not.
Nov 23, 2022
0
78
While diabetes is already associated with an increased risk of developing breast cancer, a new Vanderbilt study published in Science Advances on November 18 indicates that presence of the disease may increase tumor growth ...
Nov 21, 2022
0
16
A promising new study released by the University of Colorado Cancer Center suggests that recurrence of certain cancers can be significantly decreased by irradiating only a select set of lymph nodes near a tumor rather than ...
Nov 16, 2022
0
78
New technology can trace which populations of breast cancer cells are responsible for the spread of the disease, and for the first time highlights how the location of cancer cells could be as important as mutations in tumor ...
Nov 9, 2022
0
33
Some cancer cells can deploy parallel mechanisms to evade the immune system's defenses as well as resist immunotherapy treatment, according to a new study from the Garvan Institute of Medical Research.
Nov 7, 2022
0
65
